All Articles
-
Corporate Website Renewal Notice
-
Poster presentation at “Antibody engineering & therapeutics Asia”
-
【Update】We Will Exhibit at “Global Startup EXPO 2025”
-
‘RevoAb™’: A New Service for Antibody Developability Engineering
-
We Will Exhibit at “PEGS Europe”
-
We Will Exhibit at “Antibody Engineering 2025″
-
We Will Exhibit at “Global Startup EXPO 2025”
-
RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)
-
RevolKa Ltd. Secures 210 million JPY (US$1.4 million) Series A Extension Funding to Advance Therapeutic Programs
-
RevolKa expanding research projects with Daiichi Sankyo